Stock SNGX SOLIGENIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Soligenix, Inc.

Equities

SNGX

US8342236044

Market Closed - Nasdaq
Other stock markets
 01:30:01 2024-07-03 pm EDT 		5-day change 1st Jan Change
2.26 USD -0.44% Intraday chart for Soligenix, Inc. -17.22% -81.35%
Jun. 25 Soligenix, Inc. Announces Positive Clinical Results from A Comparative Study Evaluating Hybryte?? Against Valchlor®? in the Treatment of Cutaneous T-Cell Lymphoma CI
May. 23 Sector Update: Health Care Stocks Retreat Late Afternoon MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
SOLIGENIX : Alliance Global Adjusts Price Target on Soligenix to $3.75 From $5.75, Reiterates Buy Rating
MT
SOLIGENIX : B. Riley Lowers Soligenix' PT to $1.50 from $2 on Unchanged Valuation Methodology, Keeps Neutral Rating
MT
SOLIGENIX : B. Riley Starts Soligenix at Buy With $4 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SNGX Stock
  4. News Soligenix, Inc.
  5. Analyst Reco.